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Suppression of ILC2 differentiation from committed
T cell precursors by E protein transcription factors
Liangyue Qian1, Sandra Bajana1, Constantin Georgescu1, Vincent Peng2, Hong-Cheng Wang1, Indra Adrianto1,5, Marco Colonna2, Jose Alberola-Ila1,3,
Jonathan D. Wren1, and Xiao-Hong Sun1,3,4
Current models propose that group 2 innate lymphoid cells (ILC2s) are generated in the bone marrow. Here, we demonstrate
that subsets of these cells can differentiate from multipotent progenitors and committed T cell precursors in the thymus, both
in vivo and in vitro. These thymic ILC2s exit the thymus, circulate in the blood, and home to peripheral tissues. Ablation of E
protein transcription factors greatly promotes the ILC fate while impairing B and T cell development. Consistently, a
transcriptional network centered on the ZBTB16 transcription factor and IL-4 signaling pathway is highly up-regulated due to E
protein deﬁciency. Our results show that ILC2 can still arise from what are normally considered to be committed T cell
precursors, and that this alternative cell fate is restrained by high levels of E protein activity in these cells. Thymus-derived
lung ILC2s of E protein–deﬁcient mice show different transcriptomes, proliferative properties, and cytokine responses from
wild-type counterparts, suggesting potentially distinct functions.
Introduction
Innate lymphoid cells (ILCs) are important contributors to
protective immunity as well as to pathological conditions (Artis
and Spits, 2015; Eberl et al., 2015). Therefore, the regulation of
their homeostasis is of biological signiﬁcance. Despite the lack of
antigen receptors on their cell surface, three groups of ILCs,
designated ILC1–3, exhibit parallel cytokine expression proﬁles
and immune functions with the three subsets of T helper cells
known as Th1, Th2, and Th17 (Spits et al., 2013; Robinette and
Colonna, 2016). For example, like Th2 cells, ILC2s secrete IL-5
and IL-13. ILCs are considered ﬁrst responders to various trig-
gers upon pathogen infection, allergen exposure, and tissue
damage (Tait Wojno and Artis, 2016).
Like B and T lymphoid cells, ILCs originate from lymphoid
progenitors such as common lymphoid progenitors (CLPs) and
lymphoid primed multipotent progenitors (LMPPs; Constantinides
et al., 2014; Yang and Bhandoola, 2016; Zook and Kee, 2016). ILC
differentiation has been shown to take place in the bone marrow
(BM) through a series of precursors that descend from CLP or
LMPP and gradually lose the potential to differentiate into B, T, or
NK cells while maintaining the ability to generate ILC1, 2, and 3
(Constantinides et al., 2014; Klose et al., 2014; Yu et al., 2014, 2016;
Yang et al., 2015). Since CLP and LMPP also seed the thymus and
differentiate into T cells (Kondo et al., 1997; Balciunaite et al., 2005;
Sambandam et al., 2005), the capacity of the thymus to support ILC
development needs to be fully evaluated.
The basic helix-loop-helix transcription factors encoded by
E2A, HEB, and E2-2 genes (also known as Tcf3, Tcf12, and Tcf4)
are collectively called E proteins (Murre, 2005). E proteins are
essential for the differentiation of both B and T cells immediately
following their respective lineage commitment (Bain et al., 1994;
Zhuang et al., 1994; Barndt et al., 2000). They also bias the
multipotent progenitors toward the lymphoid fate (Dias et al.,
2008; Cochrane et al., 2009). The functions of E proteins are
impeded by a group of inhibitors called Id proteins (Sun, 1994;
Kim et al., 1999; Wang et al., 2009; Ling et al., 2014). Id2 has been
shown to be indispensable for ILC differentiation (Klose et al.,
2014; Seillet et al., 2016). A role for E proteins in suppressing an
innate lymphoid fate was ﬁrst demonstrated in our Id1 trans-
genic mice, where Id1 is expressed under the control of the lck
proximal promoter (Wang et al., 2017). In these mice, large
numbers of phenotypic and functional ILC2s were generated in
the thymus and distributed throughout the body, leading to
heightened type 2 immune responses in allergy and parasite
infection (Wang et al., 2017). In addition, speciﬁcally deleting the
E2A and HEB genes in the thymus or in both the BM and thymus
also resulted in marked increase in ILC2 production (Miyazaki
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et al., 2017; Wang et al., 2017). Collectively, these data suggest
that E proteins block the innate lymphoid fate not only in the BM
but also in the thymus. However, whether the thymus normally
contributes to ILC2 production in the body and at what devel-
opmental stages T cell precursors can divert to the ILC2 path are
poorly understood.
In the current study, we took a number of in vivo and in vitro
approaches to demonstrate a previously unappreciated capacity
of committed T cell precursors (CD4−CD8−c-kit−CD25+ [DN3]) to
differentiate into ILC2s in WT animals (Wong et al., 2012); these
ILC2s exit the thymus to the periphery. Down-regulation of E
proteins greatly enhances such a potential. As a result, periph-
eral tissues are populated with thymus-derived ILC2s, which are
found to be hyperproliferative and have different sensitivities to
ILC2 activators. Analyses of transcriptomes in the thymic ILC2s
and cells at the early time points during in vitro ILC2 differen-
tiation revealed a critical network of gene expression, primarily
centered on the ZBTB16 transcription factor and IL-4 signaling
pathway, which are repressed by E protein activities.
Results
tdTomato expression induced by the plck-Cre transgenemarks
thymus-derived ILC2 in the periphery
Previous studies showed that ectopic Id1 expression leads to
massive overproduction of ILC2 (Wang et al., 2017), which is
now conﬁrmed to be dependent on the thymus, as crossing plck-
Id1 transgenic mice with athymic nude mice did not result in
increases in ILC2 counts (Fig. S1 a). Whether this represents a
natural function of the thymus remains unknown. To address
this, we traced thymus-derived ILC2s using plck-Cre; ROSA26-
stop-tdTomato reporter mice, because the plck-Cre transgene is
found to be speciﬁcally turned on in the thymus, beginning at
the CD4−CD8−c-kit−CD25+ (DN3) stage (Shi and Petrie, 2012;
Wang et al., 2017). The plck-Cre transgene did not cause tdTo-
mato expression either in B and myeloid cells or in innate
lymphoid progenitors and ILC2s in the BM (Wang et al., 2017). In
contrast, tdTomato expression was detected in ∼30% of ILC2s in
the thymus, suggesting that a fraction of ILC2s in the thymus
differentiated from thymic progenitors, which already turned
on the plck-Cre transgene, or that these ILC2s expressed the
transgene themselves (Fig. 1 a). Interestingly, we also observed a
similar percentage of tdTomato+ ILC2s in the blood, suggesting
that thymic ILC2s exit the organ, circulate through the blood,
and home to peripheral tissues. The generation of these tdTo-
mato+ ILC2s is dependent on the thymus, because signiﬁcantly
lower numbers of these cells were found in the blood of athymic
nude recipients of plck-Cre; ROSA26-stop-tdTomato BM pro-
genitors compared with CD45.1 recipients (Fig. S1 b).
Of the peripheral tissues examined, we detected ∼10% of
tdTomato+ ILC2s in the lung. These lung tdTomato+ ILC2s were
unlikely to be contaminating blood ILC2s because intravenous
injection of anti-CD45 antibodies shortly before harvesting lung
cells did not mark ILC2s (data not shown; Huang et al., 2018). In
contrast to the lung, few ILC2s in the white adipose tissue and
small intestine were labeled with tdTomato, whereas 1–3% of
ILC2s in the skin were tdTomato+ (Fig. 1 a). Together, these
results suggest that thymic ILC2s can populate the peripheral
tissues through circulation, even though the possibility that
ILC2s in peripheral tissues expressed the plck-Cre transgene
independently has not been ruled out.
We next generated plck-Cre; ROSA26-stop-tdTomato; E2Af/f;
HEBf/f mice, in which Cre-mediated deletion resulted in E2A and
HEB ablation and tdTomato expression. In these mice, >60% of
thymic ILC2s were labeled by tdTomato (Fig. 1 b). Furthermore,
the majority of ILC2s in other organs are also marked (Fig. 1 b).
This is likely due to the massive output of ILC2s from the thy-
mus, which resulted in >10-fold increases in ILC2 counts in
different tissues (Fig. 1 c). Since plck-Cre is expressed largely
after the DN3 stage (Wang et al., 2017), this raises the possibility
that ILC2 differentiation can occur in committed T cell pre-
cursors such as DN3 cells and suggests that E proteins normally
act to suppress the ILC2 potential in these T cell precursors.
Detection of TCRβ and TCRγ gene rearrangement in
thymus-derived ILC2s
Taking advantage of the sequential events of TCR gene rear-
rangement during T cell development in the thymus (Mombaerts
et al., 1992; Dudley et al., 1994), wemeasured TCR recombination
events in ILC2s to assess the relationship between ILC2s and
T cell precursors. We ampliﬁed representative rearranged TCR
gene products using conventional PCR with primers binding to
the V, D, or J regions of different TCR genes. ILC2s from different
organs were sorted with extra efforts to eliminate T cell con-
taminations (Fig. S2 a). To facilitate semiquantitative estimation,
we created standard curves by using cell mixtures of different
proportions of BM Mac1+ cells and total thymocytes (Fig. 2). BM
ILC2s of WT mice had few TCR rearrangement events (Fig. 2, a
and b). However, thymic ILC2s contained both Dβ2-Jβ2 and Vβ3-
DJβ2 rearrangement of the TCRβ gene, and approximately half of
the ILC2s had the TCRβ gene rearranged estimated based on
the standard curves. The PCR product corresponding to the
germline conﬁguration was also detectable (Fig. 2 a). In ad-
dition, WT thymic ILC2s exhibited robust Vγ1-Jγ4 recombi-
nation (Fig. 2 b). The quantities of the DNA preparations were
veriﬁed by PCR ampliﬁcation of a fragment in the ROSA26
locus (Fig. 2 c).
Besides thymic ILC2s, ILC2s from the WT lung also displayed
low levels of TCRβ and TCRγ gene rearrangement (Fig. 2, a and
b), which is estimated to account for ∼5–10% of the level seen in
total thymocytes. These rearrangement events were detected in
lung ILC2s from TCRα−/− but not nudemice (Fig. 2, a and b), thus
indicating that events are thymus dependent and unlikely due to
T cell contamination. These results suggest that a small fraction
of lung ILC2s come from the thymus.
In contrast to WT ILC2s, the majority of ILC2s from the
thymus and lung of the E2A and HEB double knockout mice
(plck-Cre; E2Af/f; HEBf/f [dKO]) possessed the rearranged TCRβ,
as the germline band of the TCRβ gene was undetectable (Fig. 2
a). TCRγ gene rearrangement was also readily detectable. These
results suggest that ILC2s in the dKO mice are generated from
committed T cell precursors such as DN3 cells, which already
completed TCRβ and/or TCRγ gene rearrangements. These
ﬁndings are consistent with the reporter analyses shown in
Qian et al. Journal of Experimental Medicine 885
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Fig. 1. Interestingly, thymic ILC2s from homozygous Id1 trans-
genic mice (Id1tg/tg), which also harbor a large amount of ILC2s
in the thymus and elsewhere, did not show TCR rearrangement
(Fig. 2, a and b). This is likely because ILC2s in Id1tg/tg mice
differentiated from progenitors that have not initiated TCR re-
arrangement. Although the Id1 and Cre transgenes are both
driven by the lck proximal promoter, the timing of transgene
expression may be different due to their different sites of inte-
gration. plck-Id1 is likely expressed before the DN2 stage, when
few DN2 cells weremarked by plck-Cre (Wang et al., 2009, 2017).
As a result, the tdTomato reporter induced by plck-Cre labeled a
very small fraction (∼10%) of thymic ILC2s in heterozygous Id1
transgenic mice, which have a leaky block in T cell development
(Wang et al., 2017). We would predict that the thymuses of
Figure 1. Thymic ILC2s are traced with tdTomato expression induced by the plck-Cre transgene. (a) Representative gating strategies for analyses of
tdTomato expression in ILC2s from plck-Cre; ROSA26-stop-tdTomato reporter mice. Cells from indicated organs were stained for lineage markers together
with antibodies against Thy1 and ST2 (except skin and small intestine). Live CD45+ cells were gated before lineage analysis. To ensure the elimination of any
contamination of T lineage cells, the Lin− population of each organ was further gated for TCRβ−γδTCR− based on staining with antibodies conjugated with
different ﬂuorophores from those used for lineage staining. The resulting population was then analyzed for Thy1 and ST2, and the double-positive cells were
considered ILC2s (except skin and small intestine). For skin and small intestine cells, Lin−Thy1.2+CD103+ICOS+ and Lin−Thy1.2+GATA3+RORγt− populations,
respectively, were deﬁned as ILC2s. The bar graph at the bottom shows the average percentages of tdTomato+ ILC2 cells from pooled data of several ex-
periments, and the number of each organ analyzed is as indicated. (b) Representative organs of plck-Cre; ROSA26-stop-tdTomato; E2Af/f; HEBf/f mice were
analyzed as described for panel a (n = 4 for each organ). (c) Percentage of ILC2s of total CD45+ cells in indicated organs of mice shown (a) and quantiﬁed for
statistical analysis (b). Student’s t test was used to determine statistical signiﬁcance for each organ. Error bars are SEM. **, P < 0.01; ****, P < 0.0001. Thy,
thymus; WAT, white adipose tissue; SiLP, small intestine lamina propria.
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Id1tg/tg mice have an even lower percentage of tdTomato+
ILC2s. In any case, the different status of TCR gene re-
arrangements between Id1 transgenic and E protein dKO
ILC2s suggests that ILC2s can arise from different T cell
precursors.
Thymic ILC2s up-regulate ILC2 signature genes while
down-regulating T cell–speciﬁc genes
Phenotypic studies of Id1 transgenic and E2A/HEB double
knockout mice revealed robust ILC2 differentiation in the thy-
mus as a result of loss of E protein function. To examine the
changes in the transcriptional proﬁles as T cell progenitors di-
vert to the innate lymphoid path, we performed RNA sequencing
(RNA-seq) analyses of ILC2s isolated from the thymus of Id1tg/tg
(Id1) and plck-Cre; E2Af/fHEBf/f (dKO) mice, respectively. Data
were then analyzed in comparison to that of WT DN3 thymo-
cytes (Zhang et al., 2012). As shown in the volcano plots, Id1 and
dKO ILC2 each exhibited sets of up- and down-regulated genes
relative to DN3 cells, some of which are of particular in-
terests and are highlighted in the plots (Fig. 3 a). The Venn
diagram revealed 641 genes that are differentially expressed
by both Id1 and dKO ILC2s compared with DN3 cells
(Fig. 3 b).
We then focused on this common gene set for further anal-
yses. Unsupervised hierarchical clustering analysis shows two
large clusters, designated as clusters 1 and 2 (Fig. 3 c). Cluster
1 contains genes highly expressed in DN3 cells and is repre-
sented by a set of genes essential for T cell differentiation
(Fig. 3 c). Cluster 2 is enriched in genes up-regulated in both Id1
and dKO ILC2s, many of which are known to be associated with
ILC identity and/or function (Fig. 3 c). Additionally, ingenuity
pathway analysis (IPA) established connections between these
differentially expressed genes and suggested Zbtb16 and Id2/3
plus IL4 as critical nodes (Fig. 3 d). Remarkably, 23 of the ZBTB16
target genes including those essential for ILC2 differentiation (e.
g., Rora and Id2) were included in our differentially expressed
gene set (Mao et al., 2016). Taken together, these data suggest
that down-regulation of E protein function leads to the switch
from T cell to ILC fate.
Committed T cell progenitors can differentiate into functional
ILC2s in vitro
To directly test whether committed T cell precursors such
as DN3 cells have the potential to differentiate into ILC2s, we
used the OP9-DL1 stromal cell coculture system to monitor ILC2
differentiation in vitro (Schmitt and Zuniga-Pﬂucker, 2002;
Constantinides et al., 2014; Yang et al., 2015). Different pro-
genitors (CLP, DN1, and DN3) were sorted from WT mice with
high purity (Fig. S2 b), plated onto OP9-DL1 stromal cells, and
cocultured in medium containing 30 ng/ml each of IL-2, IL-7,
and stem cell factor as described by Yang et al. (2015) (Fig. 4 a).
Cultured cells were then analyzed at different time points by
staining for surface marker expression after gating out any
TCRβ+ or TCRγδ+ cells. Fig. 4 a illustrates the analysis of the
culture on day 10. As ILC2s differentiate, they express ICOS and
CD25, but the level of α4β7 is transiently increased and then
decreased. Ultimately, ICOS+NK1.1−CD25+α4β7− cells were
considered ILC2s (Constantinides et al., 2014). The time course
of ILC2 differentiation shown in Fig. 4 b indicated that CLP,
DN1, and DN3 all differentiated robustly. On day 7, DN1 and
DN3 differentiated at similar efﬁciencies, whereas CLP lagged
behind. At later time points, DN3 cultures plateaued much
earlier than DN1 and CLP cultures (Fig. 4 b), probably due to a
lower capacity of DN3 cells to expand in this culture condition.
The different kinetics could also be used to argue against the
notion that ILC2s in the DN3 culture were derived from rare
contaminating cells such as DN1 or DN2. Considering the rel-
ative abundance of DN3 over DN1 cells, DN3 could contribute to
signiﬁcant proportions of ILC2s generated in the thymus even
with a lower capacity on a per-cell basis.
To further exclude the possibility that DN3 cells used to
initiate the culture are contaminated with ILC2s or earlier T cell
precursors in the thymus, we cultured sorted DN1 or DN3 cells in
the medium containing IL-7 and IL-33 with or without IL-2, in
comparison to the condition in Fig. 4, a and b. Both DN1 and DN3
Figure 2. TCR gene rearrangement in ILC2s. ILC2s from different organs of
C57BL/6J (WT), Id1tg/tg (Id1), plck-Cre; E2Af/f; HEBf/f (dKO), B6 (SJL)-Foxn1nu-2J;
GrsrJ (Nude), and TCRα−/− mice were sorted for DNA preparation. The con-
centration of each sample was adjusted based on the input number of cells
(500 cells/µl). Standard curves were generated by using DNA from mixtures
of Mac1+ BM cells and total thymocytes. (a and b) Rearrangement events of
the TCRβ (a) and TCRγ (b) loci were analyzed. Brackets indicate multiple
rearranged gene products for TCRβ. Arrow points to the germline pro-
duct of TCRβ ampliﬁed with primers binding to Dβ2 and Jβ2. (c) Control
for DNA quantity was performed using primers amplifying the ROSA26
gene. Approximate molecular weights of select PCR products are
shown on the right. Data shown are representative of at least three
experiments.
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cells produced large numbers of ILC2s in medium containing
IL-2 and IL-7 plus IL-33 or SCF when measured on either day
10 or 13 (Fig. 4 c). In the absence of IL-2, DN1 cells could
generate ILC2s, but DN3 cells failed to do so. The DN3 yield of
ILC2 under this condition was less than one cell per input after
13 d, whereas inclusion of IL-2 in the medium allowed ILC2
production at least 600 times more efﬁciently (Fig. 4 c). These
ﬁndings are consistent with a previous report which con-
cluded that DN3 cells could not differentiate into ILC2s when
supplied with IL-7 and IL-33 only (Wong et al., 2012). Ap-
parently, IL-2 is necessary for ILC2 differentiation from DN3
cells in vitro. This result also ruled out the possibility that
ILC2s detected in our original DN3 cultures were due to the
expansion of contaminating thymic ILC2s or DN1 cells in the
DN3 preparations, which would have expanded in the pres-
ence of IL-7 and IL-33.
To functionally verify the identity of these phenotypic ILC2s,
we switched the cultured cells to a stroma-free condition in a
medium supplemented with ILC2 activating cytokines (IL-25
and IL-33 for 3 d). Both DN1- and DN3-derived ILC2s were ca-
pable of producing ILC2 signature cytokines, IL-5 and IL-13, as
efﬁciently as those generated from CLPs, with or without fur-
ther stimulation with PMA and ionomycin (Fig. 4, d and e).
Thus, our results indicated that both multipotent progenitors
and committed T cell precursors in the thymus can differentiate
into functional ILC2s in vitro.
Loss of E proteins potentiates ILC2 differentiation in vitro and
in vivo
As loss of E proteins led to ILC2 expansion in vivo (Fig. 1), we
tested its impact on ILC2 differentiation in vitro. We initially
isolated DN3 cells from control and plck-Cre; E2Af/f; HEBf/f mice
and placed them in the coculture system described above. After 7
d, E protein–deﬁcient DN3 cells generated many more ILC2s
than those from control mice, demonstrating the suppressive
effects of E proteins on ILC2 differentiation at the DN3 stage
(Fig. S3). However, this experiment could not rule out the pos-
sibility that the DN3 cells sorted from the dKOmicewere already
skewed toward the ILC2 cell fate.
We next employed an inducible system to ablate E pro-
teins by generating ROSA26-CreERT2; ROSA26-stop-tdTomato;
E2Af/f/HEBf/f mice along with ROSA26-CreERT2; ROSA26-stop-
tdTomato mice as controls. The impact of E proteins on ILC2
differentiation from CLP, DN1, and DN3 cells was then evalu-
ated by deleting the two E protein genes with 4-hydroxyl-
tamoxifen (4-OHT) after the initiation of the coculture on
OP9-DL1 stromal cells with appropriate cytokines (Fig. 5 a).
When 4-OHT was added on day 4 and left in the culture for
three more days, it induced efﬁcient deletion as indicated by
the expression of tdTomato in 70–90% of the cells (Fig. 5 b).
CLPs differentiated more slowly, and the cultures were ana-
lyzed on day 14. Loss of E proteins led to a 20-fold increase in
the number of ILC2s produced (Fig. 5 c). In contrast, DN1- and
Figure 3. Thymus ILC2s up-regulate ILC2
signature genes while down-regulating
T cell–speciﬁc genes. RNA-seq was performed
in duplicates on ILC2s isolated from plck-Cre; E2Af/f;
HEBf/f (dKO ILC2) or Id1tg/tg (Id1 ILC2) mice and
compared with data from CD4−CD8−CD44−CD25+
DN3 cells (WT DN3). (a) Volcano plots depict dif-
ferentially expressed genes comparing ILC2 and
DN3 cells. Blue and red dots represent genes down-
and up-regulated in ILC2 bymore than fourfold with
FDR < 0.0001, respectively. Genes of interest are
labeled. (b) Venn diagrams were generated using
differentially expressed (DE) genes (more than
fourfold and FDR < 0.0001) in the indicated com-
parison using the Venny 2.1 program. Common DE
genes are shown in the overlapping area. (c) The
heatmap on the left shows the common DE genes
(base mean >100) analyzed using unsupervised hi-
erarchical clustering of normalized counts with the
Morpheus program. Selected T cell and ILC signa-
ture genes are shown on the right. (d) IPA shows
the top network of the common DE genes. Red
and green indicate up- and down-regulated genes,
respectively.
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DN3-derived cells could be evaluated on day 11, and E protein
deﬁciency resulted in 42- and 30-fold enhancement in ILC2
differentiation, respectively (Fig. 5, d and e). These results thus
suggest that E proteins can suppress the ILC2 cell fate at mul-
tiple stages of T lymphopoiesis, including a committed T cell
precursor stage, DN3. In addition, these E protein–deﬁcient
ILC2s were capable of producing IL-5 and IL-13 efﬁciently in
response to stimulation with IL-25 and IL-33 (data not shown).
Using similar inducible mouse models, we next evaluated the
effects of inducible E protein ablation in vivo (Fig. 6). To delete E
protein genes, tamoxifen was administered daily to 3-wk-old
E2Af/fHEBf/f mice with or without the ROSA26-CreERT2 trans-
gene for 9 d and analyzed 6 d after the last dose of tamoxifen
(Fig. 6 a). This regimen was found to be highly efﬁcient in Cre-
mediated deletion when tested by using ROSA26-CreERT2;
ROSA26-stop-tdTomato; E2Af/f/HEBf/f and ROSA26-CreERT2;
ROSA26-stop-tdTomato mice (data not shown). In the BM, the
number of ILC progenitors increased more than twofold in E
protein–deﬁcient mice compared with controls (Fig. 6 a). Fur-
thermore, the number of newly made ILC2s, called ILC2Ps
(Hoyler et al., 2012; Yu et al., 2014), was boosted ﬁvefold by E
protein ablation (Fig. 6 a). These changes were accompanied by a
reduction in B lymphopoiesis but not in myeloid differentiation
(Fig. 6 a). In the thymus, ILC2 levels increased ∼10-fold due to E
protein deﬁciency (Fig. 6 a). Like the situation in the BM, this
was concomitant with diminished T cell production, as the
numbers of T cells at all developmental stages were dramatically
reduced (Fig. 6 a and data not shown). Finally, we detected a 10-
fold increase in ILC2 counts in peripheral organs such as the
lung. This is likely due to increased output from the BM and
thymus, although we have not yet ruled out enhanced local
expansion.
With regard to other immune cell types, we examined their
production in the BM and thymus of these inducible mice
(Fig. 6 b). BM ILC1 and ILC3 were found to be unaltered upon E
protein deletion. However, the numbers of dendritic lineage
cells including pre-conventional DC (cDC) and plasmacytoid
dendritic cells (pDCs) decreased, consistent with the known
function of E proteins in the differentiation of these cells (Cisse
et al., 2008; Kee, 2009; Sichien et al., 2016). BM NK cells were
also diminished, probably as a result of increased divergence of
CLPs toward the innate lymphoid lineages, speciﬁcally ILC2s.
Thymic NK levels were similar with or without E protein dele-
tion. We also determined the ability of DN thymocytes in these
inducible mice to generate cytokines known to be produced by
NK and ILC lineage cells (Fig. 6 c). With the exception of IL-5 and
IL-13, we did not see any marked increase in IL-17, IL-22, IFNγ,
or IL-4 expression. Collectively, these data suggest that the levels
of E proteins are speciﬁcally crucial for restraining ILC2
differentiation.
Transcriptional proﬁling at early stages of ILC2 differentiation
To understand the changes in gene expression at the onset of
ILC2 differentiation and the impact of E protein deﬁciency, we
Figure 4. Committed T cell precursors are
able to differentiate into functional ILC2s
in vitro. (a) Progenitors from the BM (CLP) and
thymus (DN1 and DN3) were isolated from WT
mice and cultured on OP9-DL1 stromal cells in
the presence of IL-2, IL-7, and SCF for 10 d.
Representative gating strategies for identi-
fying ILC2s generated from indicated progenitors
are shown for live CD45+ cells. ILC2s were iden-
tiﬁed as TCRβ−γδTCR−ICOS+NK1.1−CD25+α4β7−,
as labeled in the ﬁnal gate. (b) Time course of
ILC2 differentiation from indicated progenitors
(n = 4). Data shown are representatives of at
least six independent experiments. Two-way
ANOVA shows P < 0.0001. Error bars are
SEM. (c) WT DN1 and DN3 cells were set up on
OP9-DL1 stromal cells as in panel a with media
containing indicated cytokines. The concentra-
tion of all cytokines was 30 ng/ml, except that
IL-33 was used at 10 ng/ml. ILC2 production at
indicated time points was measured as de-
scribed in panel a. Bar graphs show average
percentage of three or four replicates and are
representatives of three independent repeats.
One-way ANOVA was used for statistical anal-
yses. Error bars are SEM. *, P < 0.05; **, P <
0.01; ***, P < 0.001. (d) Cytokine production
was measured after incubating cells from the
14-d coculture as in panel a for three more days
in stromal-free medium supplemented with IL-2, IL-7, IL-33, and IL-25 followed by PMA plus ionomycin stimulation for 2 h. IL-5 and IL-13 production in TCRβ−
γδTCR−ICOS+CD25+ ILC2 cells was determined. (e) Quantiﬁcation of percentages of IL-13+ and IL-5+IL-13+ ILC2 as shown in panel d. Cytokine production
without treatment with PMA and ionomycin was also measured as included in the graph. Bar graphs show average percentage of replicates (n = 4) of one of
three independent experiments. One-way ANOVA was used to determine statistical signiﬁcance between DN1 or DN3 and CLP cultures after PMA plus
ionomycin stimulation. Error bars are SEM. One-way ANOVA was used for statistical analyses. ns, not signiﬁcant.
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took advantage of the in vitro differentiation system and
performed RNA-seq analyses in a time course. DN1 and DN3
thymocytes were isolated from ROSA26-CreERT2; ROSA26-
stop-tdTomato and ROSA26-CreERT2; ROSA26-stop-tdTomato;
E2Af/f/HEBf/f mice. These cells were placed on OP9-DL1 stromal
cells in the presence of IL-2, IL-7, and SCF as described for
Fig. 5. On day 4, 4-OHTwas added after an aliquot was collected
for RNA isolation. On days 5 and 7, aliquots of cells were har-
vested, and tdTomato+ cells, which are presumed to have un-
dergone Cre-mediated deletion, were sorted for RNA isolation
(Fig. 7 a). At these time points, tdTomato+ cells were also scored
for ILC2 differentiation (Fig. S4).
To evaluate the data, we ﬁrst took a candidate approach and
examined the expression proﬁles of genes known to be related to
ILC2 differentiation (Fig. 7 b). Although few phenotypic ILC2s
were detected on day 5, expression of a number of genes began
to increase within 24 h after the initiation of E protein gene
deletion, but not in the control cells. On day 7, the levels of these
genes in dKO cells continued to rise while the controls barely
began to up-regulate them. In general, DN1 and DN3 displayed
similar patterns of gene expression in these analyses, with mi-
nor variations mainly attributed to the different basal levels in
DN1 and DN3 cells on day 4. Strikingly, several transcription
factor genes, including Zbtb16, Gata3, Rora, Tox, and Lmo4, were
induced shortly following E protein ablation on day 5, but they
only became noticeable on day 7 in control cells. As a result, an
array of their downstream targets such as Icos, IL4, Il9r Il18r, and
Il18rap and Id2were also up-regulated. Itga4 and Itgb7 are known
be regulated by IL-4 signaling and were also dramatically in-
creased in dKO cells. Interestingly, IL2r and IL7r were highly
expressed in both dKO and control DN1-derived cells. Although
cytokines for these receptors were supplied in the culture, IL-
2 and IL-7 signals alone are not sufﬁcient to drive robust ILC2
differentiation. For DN3-derived cells, Il2ra expression was
preferentially up-regulated in dKO cells. Likewise, Tcf7 expres-
sion did not appear to be a rate-limiting factor for ILC2 differ-
entiation comparing dKO and control cells.
To identify sets of genes that behaved similarly over the time
course, we used the Hierarchical Ordered Partitioning and Col-
lapsing Hybrid (HOPACH) algorithm (see Materials and meth-
ods), which grouped 3,938 of the 22,000 genes examined into six
clusters for both DN1- and DN3-initiated cultures.While changes
in gene expression for groups 1, 4, and 6 were rather modest,
genes in groups 3 and 5 were continuously up-regulated, and
group 2 genes were down-regulated during the course of dif-
ferentiation. Interestingly, the genes shown in Fig. 7 b all be-
longed to group 3 except Id2, Rarg, Tcf7, and Il7r, suggesting that
this group of genes are closely related to ILC2 differentiation.
Indeed, IPA showed that group 3 genes are associated with T
helper cell differentiation and activation, glycolysis, and ICOS-
ICOSL signaling (Fig. S5 a), and it also revealed the regulatory
networks centered on ZBTB16, GATA3, STAT1, and STAT3 tran-
scription factors, as well as on IL-4 and IL-2 signaling pathways
(Fig. S5 b).
Figure 5. ILC2 differentiation is enhanced by ablation of E proteins in vitro. (a) The experimental scheme. CLP, DN1, and DN3 cells were sorted from
indicated strains of mice and placed onto OP9-DL1 stromal cells for coculture as described in Fig. 4 a. On day 4, 4-OHT was added to induce CreERT2 function.
(b) Efﬁciency of induction by tamoxifen in culture. Expression of tdTomato in CD45+ cells were measured 3 d after addition of 4-OHT and shown in histograms.
(c–e) Live CD45+tdTomato+TCRβ−γδTCR− cells from CLP (c), DN1 (d), and DN3 (e) cocultures were analyzed, and the gating strategies of ILC2s are shown.
Numbers of tdTomato+ ILC2s per input of indicated progenitors at indicated time points are shown on the right (n = 4). Data shown are representative of two
experiments. Student’s t test was used to determine statistical signiﬁcance. Error bars are SEM. **, P < 0.01; ****, P < 0.0001.
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Group 5 contains genes involved in DNA repair and cell cycle
regulation, but the statistical signiﬁcance (P values) of these
changes were several orders of magnitude lower than those in
group 3 (Fig. S5 a). Group 2 encompasses large sets of down-
regulated genes related to cell migration and cell adhesion.
However, the interpretation of this group of genes may be
complicated by a potential contamination of stromal cells in the
day 4 samples.
Distinct functionalities of thymus-derived ILC2s
Principal component analyses revealed that ILC2s from different
progenitors or in different tissues exhibit diverse tran-
scriptomes to a varying degree (Fig. 8 a). Although lung ILC2s
from WT, Id1, and dKO mice are similar relative to other ILC2
populations, they exhibit differences in their transcriptional
proﬁles among themselves, which suggest that they may possess
distinct functions. Histological examination of lung tissues of
Figure 6. Inducible ablation of E proteins promotes ILC2 differentiation in vivo. (a) ROSA26-CreERT2; E2Af/f; HEBf/f and control (E2Af/f; HEBf/f or
ROSA26-CreERT2) mice were treated to induce the deletion of E proteins as diagrammed on the top. The deﬁnitions of the BM populations are ILCP (Lin−Thy1.2
+IL-7+ST2−Sca-1−cKit+α4β7+PD-1+), ILC2P (Lin−Thy1.2+IL-7+ST2+Sca-1+CD25+α4β7+), B cells (B220+CD19+), and myeloid cells (Mac-1+). ILC2s in the thymus and
lung are Lin−Thy1.2+ST2+. Total cell numbers of each indicated subset were quantiﬁed. Data shown are pooled from three experiments (n = 5–8). (b) Lineage
cocktails for BM ILC1, BM ILC3, and BM NK include antibodies against FcεRI, B220, CD19, Mac-1, Gr-1, Ter-119, CD3ε, CD5, and CD8α. BM ILC1 were deﬁned as
Lin−Thy1.2+IL-7R+CD62L−CD27+ST2−; BM ILC3 as Lin− Thy1.2+IL-7R+CD62L−CD27−ST2−; and BM NK as Lin−Thy1.2+IL-7R−CD62L+NK1.1+DX5+. Lineage markers
for BM pre-cDC and BM pDCs are CD3, CD8α, CD5, TCRβ, γδTCR, NK1.1, Ter119, and Ly6G. BM pre-cDCs were gated as Lin−B220−MHCII−CD11c+Flt3+Sirpα−
and BM pDCs as Lin−B220+CD19−SiglecH+. Thy NKs were considered as Lin (CD3, CD8α, CD4, TCRβ, ΥδTCR)−CD122+NK1.1+DX5+. Data shown are pooled from
three independent experiments (n = 8–10). Student’s t test was used to determine statistical signiﬁcance. Error bars are SEM. *, P < 0.05; **, P < 0.01; ***, P <
0.001; ****, P < 0.0001; ns, not signiﬁcant. (c) Thymocytes from mice used in panel a were cultured in the presence of PMA and ionomycin plus monensin for
4 h before intracellular staining and analyzed with indicated antibodies. Data shown are representatives from two independent experiments.
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2-mo-old mice revealed widespread spontaneous inﬁltration of
immune cells near vasculatures in Id1 and dKOmice, resembling
the lung pathology caused by IL-33 administration (Fig. 8 b;
Zhiguang et al., 2010; Li et al., 2014). Whether this is simply due
to the overabundance of ILC2 in the lung of thesemutantmice or
reﬂects any functional differences remains to be further
investigated.
We have previously demonstrated heightened type 2 immu-
nity during parasite infection and allergen challenge in Id1 mice,
but it was not clear if this was due to a cell-intrinsic effect or
because of the increased ILC2 counts (Wang et al., 2017). We
therefore compared the responses of lung ILC2s isolated from
WT, Id1, and dKO mice to ILC2 activators in vitro. Equal num-
bers of cells were initially plated in medium containing IL-2 and
IL-7 with or without IL-25 or IL-33 and cultured for 3 d. Inter-
estingly, Id1 and dKO ILC2s proliferated much faster when IL-25
or IL-33 was added (Fig. 9 a). Staining for Ki67 also conﬁrmed
the higher proliferative potential of these cells under these
conditions (Fig. 9, b and c). Moreover, there was a striking dif-
ference in the percentage of Ki67+ cells in cells cultured with IL-2
and IL-7. Only∼10% ofWT ILC2swere Ki67+, but Id1 and dKO cells
had 40% (Fig. 9, b and c). Although Ki67 expression in ex vivo lung
ILC2s of all three genotypes are very low (Fig. 9 d), WT cells re-
mains in the resting state, while a large fraction of Id1 and dKO
cells are ready to proliferate before stimulation with IL-25 or IL-
33, suggesting that Id1 and dKO ILC2s are more poised for ex-
pansion if given appropriate stimuli.
With regard to the abilities to produce type 2 cytokines when
exposed to ILC2 activators, we performed intracellular staining
to measure the responses on an individual cell basis and ELISA
to gauge the collective outcomes. In the presence of IL-2 and IL-7
alone, very few cells expressed IL-5 or IL-13 (Fig. 10 a). Addition
of IL-25 stimulated cytokine productionmore robustly in Id1 and
dKO cells, whereas IL-33 was more effective on WT ILC2s
(Fig. 10 a). Analyses of mean ﬂuorescence intensity of IL-5+ or
IL-13+ cells revealed that Id1 and dKO ILC2s express slightly
higher levels of IL-5 and IL-13 in the presence of IL-25 but WT
ILC2s produced signiﬁcantly higher levels of cytokines when
cultured in IL-33 (Fig. 10 b). This result is consistent with the
ELISA data which shows the accumulation of IL-5 and IL-13 in
the course of 3 d (Fig. 10 c). Relative toWT cultures, Id1 and dKO
cultures had higher levels when stimulated with IL-25 but lower
levels in the presence of IL-33. We note that the cell numbers at
the end of the culture with the three genotypes were different,
which would impact cytokine yields. However, it is difﬁcult to
simply calculate cytokine production on a per-cell basis due to
the unknown kinetics of cytokine secretion and stability of the
cytokines. Nevertheless, the trends are that Id1 and dKO ILC2s
Figure 7. Transcriptional proﬁling at the early stages of ILC2 differentiation. (a) Experimental scheme. DN1 and DN3 thymocytes from ROSA26-CreERT2;
ROSA26-stop-tdTomato; E2Af/f; HEBf/f (dKO) and ROSA26-CreERT2; ROSA26-stop-tdTomato (control) mice were cocultured as in Fig. 5 a. Biological duplicates
were collected on days 4 (D4), 5 (D5), and 7 (D7) for RNA isolation for RNA-seq. D5 and D7 cells were sorted for tdTomato expression. (b) Normalized read
counts of candidate ILC signature genes in DN1- or DN3-initiated cultures were plotted in heatmaps with unsupervised hierarchical clustering using the
Morpheus program. (c) Gene expression variation proﬁles over the time course. Six groups of similar expression variation proﬁles were identiﬁed among 3,938
genes, using the HOPACH algorithm. Trends of gene expression changes are depicted in color-coded lines, and the numbers next to the legend of each line
show the number of genes in each group.
Qian et al. Journal of Experimental Medicine 892
ILC2 differentiation from thymic T cell precursors https://doi.org/10.1084/jem.20182100
D
ow
nloaded from
 https://rupress.org/jem
/article-pdf/216/4/884/845914/jem
_20182100.pdf by W
ashington U
niversity In St. Louis Libraries user on 27 D
ecem
ber 2019
are slightly more responsive to IL-25 than WT cells, whereas
WT cells are more sensitive to IL-33.
We also evaluated the responses of these ILC2s to two well-
known neuropeptides, neuromedin U (NMU) and vascular in-
testinal peptide (VIP), in the presence of IL-2, IL-7, and IL-25
(Nussbaum et al., 2013; Klose et al., 2017; Wallrapp et al., 2017).
NMU and VIP did not stimulate cytokine production without IL-
25 (data not shown). Under the condition we used, we saw slight
additional boost by NMU inWT and dKO cells, but VIP appeared
to have signiﬁcantly synergistic effects on all three genotypes
(Fig. 10 d). Collectively, these in vitro analyses revealed some
functional differences between WT and Id1 or dKO ILC2s, which
could shed light on the potential functional specialization of
thymus-derived ILC2s.
Discussion
The capacity of the thymus to generate ILC2s has been demon-
strated here and elsewhere (Miyazaki et al., 2017; Wang et al.,
2017; Bornstein et al., 2018; Jones et al., 2018; Kernfeld et al.,
2018). The thymic environment is known to provide ample
Notch and IL-7 signals needed for ILC2 differentiation, and the
recent identiﬁcation of IL-25–producing thymic tuft cells also
provokes further interest (Gentek et al., 2013; Bornstein et al.,
2018). While it is not surprising that DN1 thymocytes, which
include early thymic progenitors with multipotent potential
(Bell and Bhandoola, 2008), can give rise to ILC2, the ability of
DN3 thymocytes to do so is unexpected. A previous study
showed that DN3s were unable to generate ILC2s when cultured
in IL-7 and IL-33 (Wong et al., 2012). We now show that IL-2 is
instrumental for the differentiation, survival, and/or expansion
of DN3-derived ILC2s in vitro. The existence of DN3-derived
ILC2s in WT mice was illustrated by tdTomato labeling with
the plck-Cre transgene, which is expressed mainly after the DN3
stage (Shi and Petrie, 2012; Wang et al., 2017), and by the de-
tection of TCRβ and TCRγ gene rearrangement events in thymic
and lung ILC2s (Figs. 1 and 2). The fact that rearrangement
events were detected in lung ILC2s of mice without the majority
of T cells (TCRα−/−) but not in mice without the thymus further
strengthens our conclusion. DN3 cells have not previously been
shown to give rise to any non–T lineage cells. Our observation
may suggest that ILCs are closer to T cells than any other cell
types. A small fraction of NK cells was previously shown to be
made in the thymus and contains TCRγ but not TCRβ gene re-
arrangement (Veinotte et al., 2006). However, DN1 thymocytes
were shown to give rise to these cells (Veinotte et al., 2006;
Vargas et al., 2011).
Figure 8. Distinct ILC2 transcriptomes and lung histology of WT, Id1,
and dKO mice. (a) Principal component analysis of ILC2 transcriptomes from
different organs of C57BL/6J (WT), Id1tg/tg (Id1), and plck-Cre; E2Af/f; HEBf/f
(dKO) mice using 2D multidimensional scaling representation. Expression
proﬁles of 5,456 genes, deferentially expressed between at least two of
the sample types under study, were used in computing distances.
Percentages show proportion of total distance among all samples,
captured by each axis. Thy, thymus; SI, small intestine. (b) Hematox-
ylin and eosin staining of lung tissues from 2-mo-old mice of the in-
dicated genotypes. Arrows indicate immune cell inﬁltration. Scale bars
represent 100 µm. Representative graphs from three mice of each
genotype are shown.
Figure 9. Increased proliferative potential of lung ILC2s of Id1 and dKO
mice. Sorted lung ILC2s (4,000 cells) from mice of indicated genotypes were
cultured for 3 d in the presence of 10 ng/ml each of IL-2 and IL-7 ± 10 ng/ml
IL-25 or 1 ng/ml IL-33. 400,000 CD45.1+ thymocytes were added as carriers
at the time of the ﬂow cytometry analyses, and counting beads were used to
determine the CD45.2+ cell numbers. Based on the recovery of CD45.1+ cells,
it was estimated that the intracellular staining procedures caused a 50% loss
of the cells. (a and b) Cell counts (a) and percentages (b) of CD45.2+Ki67+
cells are shown (n = 3). Data shown are representatives from two to three
independent experiments. Student’s t tests were used to determine the
statistical signiﬁcance between WT and mutant cells. Error bars are SEM.
*, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. (c) Representative
intracellular staining proﬁles for Ki67 expression in lung ILC2s cultured in the
indicated conditions. Data shown are representative graphs from two inde-
pendent experiments. The solid peak shows the negative control for anti-Ki67
staining. Blue line, WT; orange line, Id1; cyan line, dKO. (d) Ki67 staining of
freshly isolated lung ILC2s. Student’s t tests were used to determine the
statistical signiﬁcance. ns, not signiﬁcant.
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Deletion of the E2A and HEB genes using the plck-Cre
transgene resulted in a massive expansion of ILC2s with TCRγ
and TCRβ rearrangement, suggesting that ILC2 differentiation
occurred in committed T cell precursors. In contrast, thymic
ILC2s from Id1 transgenic mice did not show much TCR rear-
rangement (Fig. 2) and were poorly labeled by tdTomato (Wang
et al., 2017). This is likely because Id1-driven ILC2 differentiation
occurs at a much earlier stage before the initiation of TCR re-
arrangement, or that Id1 inhibits RAG gene expression and/or
reduces the accessibility of the TCR loci. Despite the different
developmental stages at which ILC2s were generated in Id1
transgenic and E protein–deﬁcient mice, their ILC2s share a
common set of genes known to be related to ILC2 identity and
function, thus suggesting that ILC2 differentiation can take place
at multiple developmental stages. E proteins are obviously
forceful in suppressing the ILC2 fate while driving T cell dif-
ferentiation. However, T cell precursors, which have lower E
protein activity due to elevated amounts of Id protein, increased
E protein turnover, or lower levels of E protein expression,
can diverge to the ILC2 path. Indeed, up-regulation of Id3
Figure 10. Different responses of Id1 and dKO ILC2s to
activators. (a) Percentages of IL-5+ or IL-13+ cells were
determined by intracellular staining after 4-h monensin
block of cells cultured as described for Fig. 9. Data shown
are representative results of three independent experi-
ments. Student’s t test was used to determine statistical
signiﬁcance between Id1 or dKO andWT ILC2. Error bars are
SEM. **, P < 0.01; ***, P < 0.001. (b) Mean ﬂuorescence
intensity of IL-5 and IL-13 in cultured lung ILC2s was de-
termined in the positive gates as shown. Solid peak shows
levels of IL-5 or IL-13 staining in cells cultured in IL-2 and IL-7
only. Blue line, WT; orange line, Id1; cyan line, dKO. Data
shown are representative results of three independent ex-
periments. Student’s t test was used to determine statistical
signiﬁcance between Id1 or dKO and WT ILC2. Error bars are
SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P <
0.0001. (c) ELISA analyses of IL-5 and IL-13 levels before
addition of monensin were performed using culture super-
natants. The concentrations of IL-5 and IL-13 were calcu-
lated based on standard curves. The levels of the cytokines
in cells cultured with IL-2 and IL-7 only were below the
background. Data shown are representative results of three
independent experiments. Student’s t test was used to de-
termine statistical signiﬁcance between Id1 or dKO and WT
ILC2. Error bars are SEM. *, P < 0.05; **, P < 0.01; ***, P <
0.001; ****, P < 0.0001. (d) Intracellular staining for IL-5 and
IL-13 in cells cultured in IL-2, IL-7, and IL-25 with or without
1 µg/ml of NMU or 1 µM VIP. Data shown are aggregates of
three independent experiments after normalization. Stu-
dent’s t test was used to determine statistical signiﬁcance
between Id1 or dKO and WT ILC2. Error bars are SEM. *, P <
0.05; **, P < 0.01; ***, P < 0.001.
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transcription and ubiquitin-mediated degradation of E pro-
teins transiently occur following preTCR signaling (Bain et al.,
2001; Nie et al., 2003), thus creating an opportunity for ILC2
digression.
Expression of the tdTomato reporter allowed us to trace the
destinations of the DN3-derived ILC2s. The frequency of tdTo-
mato+ ILC2s in the blood is readily detectable, which suggests
that thymic ILC2 can egress and circulate in the blood (Fig. 1 a).
The tdTomato+ ILC2s seen in the blood depended on the thymus,
as nude mice transplanted with BM progenitors of plck-Cre;
ROSA26-Stop-tdtomato mice had few such cells (Fig. 1 b). Since
ILC2s in both Id1 transgenic and E protein–deﬁcient mice ex-
press high levels of S1pr1 (Fig. 3 a), which encodes the receptor
known to facilitate the egress of mature T cells (Allende et al.,
2004; Matloubian et al., 2004), they have the means of exiting
the thymus. Although the half-life of these cells and their tissue
preference are not entirely clear, we did detect tdTomato ex-
pression in small fractions of ILC2s in the lung and skin, sug-
gesting these cells and possibly other unlabeled thymic ILC2s
can home to the periphery and participate in immune functions.
While this tdTomato reporter provided us with an easy tool for
identifying thymus-derived ILC2s, there are some limitations.
tdTomato expression negatively impacts cell proliferation or
survival. Although thymus speciﬁc, the timing of plck-Cre ex-
pression during T cell development was also not uniform, thus
causing some degree of variation in the frequencies of tdTomato+
ILC2s among individual mice. An alternativemarker for thymus-
derived ILC2s would greatly aid further investigation.
Comparison of transcriptional proﬁles between Id1 trans-
genic or E protein–deﬁcient ILC2 andWT DN3 thymocytes led to
the identiﬁcation of a common set of differentially expressed
genes, which includes genes speciﬁc for T cell differentiation
and genes related to ILC fates. Data from ILC2 cultures also
suggest that DN1 and DN3 cells share a common regulatory
network during ILC2 differentiation. Interestingly, this gene set
includes several genes encoding key transcription factors for ILC
differentiation, ZBTB16, Rora, and Lmo4 (Fig. 3 c). Gata3, though
important for ILC2 differentiation (Hoyler et al., 2012; Yagi et al.,
2014), is not among them because it is widely expressed in
T cells. Furthermore, analyses of gene expression during the
initiation of ILC2 differentiation in vitro also revealed the up-
regulation of a similar set of transcription factors plus GATA3
and Tox (Fig. 7, b and c). It is amazing that ablating E2A and HEB
for <24 h led to concerted up-regulation of all of these tran-
scription factors along with their downstream targets. As a re-
sult, E protein–deﬁcient cells have a tremendous advantage in
ILC2 differentiation in culture. How E proteins impact the ex-
pression of all of these transcription factors is not understood,
and it is unreasonable to expect E proteins to repress the target
genes individually. However, E proteins have been shown to
bind upstream of the promoter of Zbtb16 and activate tran-
scription in NKT cells (D’Cruz et al., 2014). Whether they play a
repressive role in the context of ILC precursors remains to be
investigated. ZBTB16 is found in this study to be a major focal
point of the transcriptional network and could thus be a prime
candidate to be regulated by E proteins. Although loss of ZBTB16
function does not abolish ILC production (Constantinides et al.,
2014), gain of its function could promote ILC2 differentiation. In
addition, E proteins have previously been shown to repress the
transcription of gata3 (Xu et al., 2013), which could help explain
how loss of E proteins leads to up-regulation of GATA3 and ILC2
differentiation in vitro. However, it is equally possible that E
proteins up-regulate other transcriptional repressors and non-
coding RNAs to suppress the innate lymphoid fate.
Apart from the key transcription factors, cytokine signaling
also plays important roles in ILC2 differentiation. Particularly,
IL-4 signaling is another node in the regulatory network re-
vealed by analyses of both ex vivo thymic ILC2 and ILC2s gen-
erated in vitro. Even though IL-4 secretion is not a major
function of ILC2s, its signaling pathway and downstream events
might be crucial for ILC2 differentiation, just as they are for Th2
polarization. In contrast, IL-2 and IL-7 are essential for the
survival and expansion of ILC2, but they may not dictate the
lineage fates of adaptive versus ILCs.
Principal component analysis of bulk RNA-seq data of ILC2s
from different tissues of WT, Id1, or dKO mice shows distinct
transcriptional proﬁles. Id1 and dKO ILC2s from the thymus
display drastically different patterns, probably reﬂecting the
different cell origins from which they arise (DN1 and DN3, re-
spectively). However, when these cells reach the lung, tissue
environment shapes their transcriptomes and makes them less
different compared with when they initially develop in the
thymus. These observations are consistent with those made
using single-cell RNA-seq, where Ricardo-Gonzalez et al. (2018)
illustrated different transcriptomes of ILC2s in different tissues
and their different dependence on cytokines. Despite the
similarity of lung ILC2s of different genotypes, Id1 or dKO
ILC2s also exhibit somewhat different transcriptional proﬁles
compared with WT ILC2s, which could lead to functional
differences.
To examine cell-intrinsic functions, we compared their re-
sponses to IL-25 or IL-33 as well as neuropeptides between ILC2s
fromWT and Id1 or dKO mice in vitro. Remarkably, Id1 and dKO
ILC2s proliferated much more avidly compared with WT ILC2s,
probably due to their higher propensity to be at an active state
(G1 or G2-M phases) even without IL-25 or IL-33 stimulation. In
terms of ILC2 activation by their activators, Id1 or dKO cells are
slightly more sensitive to IL-25 but less responsive to IL-33.
Likewise, these cells can be further activated by VIP together
with IL-25, while NMU had little synergistic effect. Whether
these differences found in vitro can be related to in vivo sit-
uations and whether Id1 or dKO ILC2s can represent WT
thymus-derived ILC2s await further investigation. These tasks
will be greatly aided by the availability of speciﬁc markers for
different subsets of ILC2s, and mutant mice lacking or enriched
with thymus-derived ILC2s will be helpful in delineating the
different characteristics of the heterogeneous population of
ILC2s in peripheral tissues.
Our discovery of the great capacity of the thymus to generate
ILC2s from different T cell precursors brings to attention the
heterogeneity of ILC2 pools in the periphery and provokes fur-
ther inquiries into any unrecognized functional differences
among different ILC2 subsets derived from the thymus and BM,
as well as during embryogenesis. These functional differences,
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once understood, could help explain the protective and harmful
effects of ILC2s in various pathophysiological situations.
Materials and methods
Mice
C57BL/6J, plck-Cre, Rosa26-STOP-tdTomato, Rosa26-CreERT2,
B6.129S2-Tcratm1Mom/J (TCRα−/−), and B6(SJL)-Foxn1nu-2J; GrsrJ
(nude) mice were purchased from the Jackson Laboratory. plck-
Id1 transgenic mice (Kim et al., 1999) and plck-Cre; E2Af/f; HEBf/f
(Wojciechowski et al., 2007) were as described. All animal ex-
periments were performed according to protocols approved by
the Institutional Animal Care and Use Committee policies at the
Oklahoma Medical Research Foundation.
Isolation of hematopoietic cells from nonlymphoid tissues
Perfused lungs were cut into small fragments and digested in
Hepes buffer (150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM
CaCl2, and 10 mM Hepes) containing 25 µg/ml Liberase TH
(Sigma) and 10 U/ml DNase I (Sigma) at 37°C for 30 min. Cells
were ﬁltered with a 70-µm cell strainer.
White adipose tissue was cut into small pieces and digested in
DMEM containing 200 µg/ml collagenase IV and 3% BSA at 37°C
for 30 min while shaking. Then, HBSS containing 0.5% BSA was
used to stop the reaction, and cells were centrifuged and ﬁltered
with a 70-µm cell strainer.
Small intestines were harvested, and Peyer’s patches were
removed. They were then opened longitudinally and cut into
small pieces. This was followed by treatment with HBSS con-
taining 1 mM EDTA for 20 min at 37°C with constant stirring.
After extensive washing, tissues were incubated with a diges-
tion buffer (RPMI containing 2% newborn calf serum (Sigma),
20 µg/ml Liberase TH, and 10 U/ml DNase I) with continuous
stirring at 37°C for 20 min. Supernatants were collected, and
residual tissue pieces were digested again for 20 min. Super-
natants from both digestions were combined and passed through
70-µm cell strainers to obtain single cells.
Dermal cells were prepared by splitting ears into dorsal and
ventral halves with forceps and were treated with 0.25% trypsin
in HBSS at 37°C for 1 h. They were then digested for 1 h at 37°C in
RPMI containing 2% newborn calf serum, 80 µg/ml Liberase TH,
and 10 U/ml DNase I. Single cells were collected after ﬁltering
digested tissues through a 70-µm cell strainer.
Flow cytometry and cell sorting
All antibodies used were purchased from BioLegend unless
speciﬁed otherwise. The lineage (Lin) cocktail included anti-
FcεR (MAR-1), anti-B220 (RA3-6B2), anti-CD19 (ID3), anti–Mac-1
(M1/70), anti–Gr-1 (R86-8C5), anti-CD11c (N418), anti-NK1.1
(PK136), anti–Ter-119 (Ter-119), anti-CD3ε (145-2C11), anti-CD5 (53-
7.3), anti-CD8α (53-6.7), anti-TCRβ (H57-597), and anti-γδTCR
(GL-3; eBioscience) unless speciﬁed otherwise. Additional anti-
bodies are anti-CD45.2 (104), anti-CD45.1 (A20), anti-CD135
(A2F10), anti-cKit (2B8), anti-Sca-1 (D7), anti-Thy1.2 (53-2.1),
anti–IL-5 (TRFK5), anti–IL-13 (eBio13A; eBioscience or Invitrogen),
anti–IL-4 (11B11), anti–IL-17A (TC11-18H10.1), anti–IL-22 (IL22JOP;
Invitrogen), anti-IFNγ (XMG1.2; eBioscience), anti–IL-7Rα (A7R34;
eBioscience), anti-α4β7 (DATK32; eBioscience), anti-CD25 (PC61),
anti–PD-1 (J43; eBioscience), anti-ST2 (DIH9), anti-ICOS (C398.4A),
anti-DX5 (HMα2), anti-CD62L (MEL-14), anti-CD27 (LG.3A10), anti-
CD122 (5H4; BD Biosciences), anti-siglecH (551), anti-MHCII (M5/
114.152), anti-Sirpα (P84; eBioscience), anti-CD103 (2E7), anti-
GATA3 (TWAJ; eBioscience), and anti-RORγt (Q31-376).
Cell sorting was performed on a FACSAria II (BD Bio-
sciences). CLP, DN1, and DN3 cells were sorted as Lin−IL-7R+Sca-
1intckitintThy1−Flt3+, Lin−ST2−cKit+CD25−, and Lin−ST2−cKit−CD25+,
respectively. ILC2 cellswere sorted as Lin−TCRβ−TCRγδ−Thy1.2+ST2+
for thymus and BM and Lin−TCRβ−TCRγδ−Thy1.2+ST2+ICOS+ for
lung. Lineage depletion were performed for thymus and BM cells
before staining for speciﬁed lineage markers and antibodies for cell
sorting as previously described (Perry et al., 2007). Brieﬂy, puriﬁed
antibodies were stained for BM lineage markers (B220, CD19,
Ter119, Gr1, and Mac1) or thymus lineage markers (CD4 and
CD8) followed by magnetic separation with BioMag anti-rat
IgG beads (Qiagen). Flow cytometric analysis was performed
on a LSR-II (BD Biosciences). Intracellular staining of tran-
scription factors was performed using a Foxp3 Staining Buffer
kit (eBioscience). Staining of cytokines was performed using a
Cytoﬁx/Cytoperm kit (BD Biosciences).
Gene rearrangement assay
Conventional PCRs were performed as described previously
(Kim et al., 1999). Brieﬂy, DNA was prepared at a concentration
of 500 cells/µl by lysing cells in a digestion buffer (10 mM Tris,
pH 8.4, 50 mM KCl, 2 mM MgCl2, 0.45% NP-40, 0.45% Tween-
20, and 60 µg/ml proteinase K), incubating at 55°C for 1 h, and
then inactivating the protease at 95°C for 2 min. DNA equivalent
to 1,000 genomes was used for PCR. Ampliﬁcation products
were detected by Southern blotting with radioactive labeled
probes. Standard curves for PCR ampliﬁcation were generated
by using DNA samples made of mixtures of BM Mac1+ cells and
total thymocytes at different proportions. PCR products were
analyzed in parallel with those generated from ILC2 samples in
Southern blotting. Controls for DNA quantity were performed
by PCR ampliﬁcation of the ROSA26 locus. Primers for Dβ2-Jβ2,
Vβ3-DJβ2, VαH-JαTT11, and Vγ1-Jγ4 rearrangement are as pre-
viously described (Capone et al., 1998; Kim et al., 1999). Primers
for ROSA26 are 59-GGAGTGTTGCAATACCTTTCTGG-39 and 59-
CGACACTGTAATTTCATACTGTAG-39. The probes for Vγ1-Jγ4
PCR products are 59-CCCTTTGGCAAATATCTTGACCCATG-39
and 59-GCTGTGTTGGAGAAATATGGAAGAGAAAC-39.
In vitro cell culture
Different progenitors were seeded in 48-well plates on OP9-DL1
stromal cells in α-MEM (Gibco) supplemented with 20% FBS,
penicillin and streptomycin, β-mercaptoethanol, and glutamine
(Sigma), as well as 30 ng/ml each of IL-2, IL-7, and stem cell
factor (R&D Systems). The culture was split and replated onto
fresh stromal layers after 7 d and then every 3–4 d. Cytokine
production by ILC2s generated from the cultures was monitored
after switching to a stroma-free condition supplemented with
10 ng/ml each of IL-2, IL-7, IL-25, and IL-33 for 3 d. To induce
ERT2-Cre in vitro, 4-OHT was added into the cultures at a ﬁnal
concentration of 1 µM on day 4 after the initiation of the culture.
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RNA-seq
RNA-seq was performed in duplicate by the Clinical Genomics
Center at the Oklahoma Medical Research Foundation using the
Ovation RNA-Seq System (NuGEN Technologies) followed by
KAPA Hyper library preparation kits (KAPA Biosystems) on an
Illumina NextSeq 500 sequencing platform with 76-bp, paired-
end reads (Illumina). In addition, transcriptomes of WT DN3
thymocytes (Zhang et al., 2012) were included in our analyses.
Raw sequencing reads (in a FASTQ format) were trimmed using
Trimmomatic to remove any low-quality bases at the beginning
or the end of sequencing reads as well as any adapter sequences
(Bolger et al., 2014). Trimmed sequencing reads were aligned to
the Mus musculus genome reference (GRCm38/mm10) using
STAR v.2.4.0h (Dobin et al., 2013). Gene-level read counts were
determined using HTSeq v.0.5.3p9 (Anders et al., 2015) with the
GENCODE Release M10 (GRCm38) annotation. DESeq2 (Love
et al., 2014) was used for read-count normalization and differ-
entially expressed analyses of ILC2s isolated from Id1 transgenic
and E protein–deﬁcient mice. Only autosomal genes coding for
lncRNAs, miRNAs, and protein-coding mRNAs were selected for
analyses. Heatmaps were created by unsupervised hierarchical
clustering using normalized read counts of differentially ex-
pressed transcripts (fold change >4, false discovery rate [FDR] <
0.0001) using the Morpheus program provided by the Broad
Institute (https://software.broadinstitute.org/morpheus/). Vol-
cano plots were generated using the R calibrate package
(Graffelman, 2013). IPA (QiagenA) was used to analyze gene
networks and pathways.
RNA-seq of cultured cells was performed in single strands.
Read-count normalization and differentially expressed analyses
was performed using the edgeR package from Bioconductor.
Expression values normalized with the voom function were
analyzed for differential expression using the standard func-
tions of the limma program. A global score, quantifying ex-
pression variation among successive time points inside each cell
type, was computed for each transcript using the F test, and the
corresponding P values were adjusted for multiple testing using
the FDR. The set of differentially expressed transcripts was
segmented into six disjoint groups of similar expression varia-
tion proﬁles, using the HOPACH algorithm implemented in the
R package of the same name. The HOPACH clustering algorithm
builds a hierarchical tree by recursively partitioning a dataset
while ordering and possibly collapsing clusters at each level. The
mean/median split silhouette criterion is used to identify the
level of the tree with maximally homogeneous clusters.
Data sharing
The RNA-seq data have been submitted to Gene Expression
Omnibus with accession nos. GSE94597 and GSE111518.
Online supplemental material
Fig. S1 shows the dependence of the thymus on ILC2 production
in Id1 transgenic mice and the appearance of tdTomato+ ILC2s in
the blood. Fig. S2 shows the post-sort analyses of samples used
for TCR rearrangement assays and in vitro cultures. Fig. S3
shows the data of in vitro ILC2 culture initiated with DN3 cells
from plck-Cre; HEBf/fE2Af/f mice. Fig. S4 shows the analyses for
ILC2 differentiation of cultured cells used for RNA-seq. Fig. S5
shows additional bioinformatics analyses of RNA-seq data.
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